SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-054792
Filing Date
2022-05-02
Accepted
2022-05-02 17:19:12
Documents
4
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm223578-1_pre14a.htm PRE 14A 1009042
2 GRAPHIC lg_hookipapharma-4c.jpg GRAPHIC 24246
3 GRAPHIC tm223578d1-pxy_proxy14c.jpg GRAPHIC 936515
4 GRAPHIC tm223578d1-pxy_proxy2bw.jpg GRAPHIC 643362
  Complete submission text file 0001104659-22-054792.txt   3215865
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38869 | Film No.: 22883291
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences